Biofourmis Closes $35 Million Series B Financing Round to Advance Artificial Intelligence-Powered Digital Therapeutics Platform

Funding to grow clinically validated solution that combines AI, drug therapies, wearable sensors and smartphone app to deliver better patient outcomes   BOSTON, May 21, 2019 /PRNewswire/ — Biofourmis, a fast-growing leader in digital therapeutics, today announced that it has successfully closed $35 million in Series B financing. The company also announced it will be expanding its Boston office and moving its […]